WeVote

Bill

Bill

A 6151

Requires labeling of over-the-counter and prescription drugs containing major food allergen or gluten-containing grain.

2024-2025 Regular Session Introduced by Lisa Swain

New Jersey bill mandates allergen and gluten labeling on all prescription and over-the-counter drugs to protect allergic patients from hidden inactive ingredient exposure.

0
WeVote Research Nonpartisan
Bill Summary · A 6151

Legislative bill overview

A 6151 would mandate that all over-the-counter and prescription medications sold in New Jersey include clear labeling identifying major food allergens (the "Big 8": milk, eggs, fish, shellfish, peanuts, tree nuts, soy, sesame) and gluten-containing grains as inactive ingredients. This labeling requirement would apply to all drug formulations, from tablets to liquids to topical preparations.

Why is this important

Millions of Americans with food allergies and celiac disease unknowingly consume allergens through medication, potentially triggering severe reactions ranging from mild discomfort to anaphylaxis. Currently, the FDA does not require standardized allergen labeling on drugs, leaving patients to contact pharmacists or manufacturers to verify safety—a gap that has documented cases of preventable adverse events.

Potential points of contention

  • Pharmaceutical industry burden: Manufacturers argue reformulating products and updating labeling is costly, potentially delaying new medications or increasing drug prices, particularly for smaller companies
  • FDA jurisdiction overlap: Federal law already governs drug labeling; critics question whether state-level mandates create conflicting standards or if this should remain a federal initiative
  • Practical enforcement challenges: Determining what qualifies as a "major" allergen, defining acceptable labeling clarity, and ensuring compliance across thousands of formulations raises implementation questions

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.